Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chemosensitivity test and its clinical application].

K Inoue1

  • 1Dept. of Clinical Oncology, Cancer Institute Hospital.

Gan No Rinsho. Japan Journal of Cancer Clinics
|October 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ion channels on synaptic vesicle membranes studied by planar lipid bilayer method.

Biophysical journal·1992
Same author

Extracellular matrix formation in piecemeal necrosis: immunoelectron microscopic study.

Liver·1992
Same author

Roles of Ca2+ influx through ATP-activated channels in catecholamine release from pheochromocytoma PC12 cells.

Journal of neurophysiology·1992
Same author

Establishment of a folliculo-stellate-like cell line from a murine thyrotropic pituitary tumor.

Endocrinology·1992
Same author

An extract of Gymnema sylvestre leaves and purified gymnemic acid inhibits glucose-stimulated gastric inhibitory peptide secretion in rats.

The Journal of nutrition·1992
Same author

[Selection of methods for diagnosis and treatment of pancreatic cancer].

Gan to kagaku ryoho. Cancer & chemotherapy·1992
Same journal

[A neuron-specific enolase (NSE) positive leiomyosarcoma].

Gan no rinsho. Japan journal of cancer clinics·1990
Same journal

[A case of synchronous multiple primary cancers of the stomach and kidney].

Gan no rinsho. Japan journal of cancer clinics·1990
Same journal

[A case of multiple peripheral pulmonary carcinoids showing a diffuse lung disease synchronously associated with sigmoid colon cancer].

Gan no rinsho. Japan journal of cancer clinics·1990
Same journal

[A well differentiated fibrosarcoma arising in left neck region].

Gan no rinsho. Japan journal of cancer clinics·1990
Same journal

[A giant struma histologically confirmed as a medullary carcinoma with multiple systemic bone metastasis].

Gan no rinsho. Japan journal of cancer clinics·1990
Same journal

[Problems associated with radical neck dissection in patients with tongue carcinoma: four cases of stage I tongue carcinoma that recurred in the cervical area after the dissection].

Gan no rinsho. Japan journal of cancer clinics·1990
See all related articles

Predicting cancer chemotherapy response is crucial for patient survival and quality of life. Human tumor clonogenic assay (HTCA) and subrenal capsule assay (SRCA) offer precise methods for determining individual chemosensitivity.

Area of Science:

  • Oncology
  • Pharmacology
  • Biomedical Assays

Context:

  • Complete response in cancer chemotherapy significantly impacts patient survival and quality of life.
  • Chemosensitivity-oriented chemotherapy is essential for optimizing treatment outcomes.
  • Accurate prediction of drug response is vital for personalized cancer care.

Purpose:

  • To evaluate the efficacy of Human Tumor Clonogenic Assay (HTCA) and Subrenal Capsule Assay (SRCA) in predicting patient chemosensitivity.
  • To compare the success rates and applicability of HTCA and SRCA for various cancer types.

Summary:

  • HTCA and SRCA are established methods for assessing individual cancer patient chemosensitivity.
  • SRCA demonstrates a higher success rate (77%) compared to HTCA (52%).

Related Experiment Videos

  • SRCA is effective for lymphomas and sarcomas, while HTCA can utilize fluid samples.

    • Impact:

    • Both assays show high predictivity for clinical drug response.
    • SRCA exhibits a particularly striking high true positive rate.
    • These assays facilitate tailored chemotherapy regimens, improving patient prognosis.